Jakob M. Riedl

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “1530P Gemcitabine/nab-paclitaxel versus (modified) FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis”.

1530P Gemcitabine/nab-paclitaxel versus (modified) FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis

Annals of Oncology(2020)10.1016/j.annonc.2020.08.2013

N/A

0DataRank · unranked

0 citations

Florian Posch, Lena Horvath, Antonia Gantschnigg, Felix Renneberg, Esther Schwarzenbacher +11 more

Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors

Annals of Oncology(2025)10.1016/j.annonc.2025.01.020

N/A

0DataRank · unranked

51 citations

Ferran Fece de la Cruz, W. Marston Linehan, Christine M. Parseghian, Jonathan Kim, Hiroyuki Matsubara +19 more